Cellectis (CLLS) Reports Q4 EPS of EUR0.59
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Join SI Premium – FREE
Cellectis (NASDAQ: CLLS) reported Q4 EPS of EUR0.59. Revenue for the quarter came in at EUR26.9 million.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clover Health Investments (CLOV) Tops Q3 EPS by 1c ; Offers Guidance
- HubSpot (HUBS) Tops Q3 EPS by 54c; offers guidance
- ZoomInfo Technologies Inc. (GTM) Reports In-Line Q3 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
